FDA Inspection 1109687 — Alnylam Pharmaceuticals Inc.
The FDA completed an inspection of Alnylam Pharmaceuticals Inc. on September 13, 2019 in Cambridge, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 13, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Cambridge, MA (United States)